Inactive Instrument
Sector Plasmatech Biopharmaceuticals Inc Nasdaq
Stocks
US72754H1095
Pharmaceuticals
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08-14 | Oppenheimer Adjusts PT on Abeona Therapeutics to $21 From $22, Maintains Outperform Rating | MT |
| 08-13 | Abeona Therapeutics Shares Fall After Q2 Miss | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.66% | +2.80% | +26.29% | +29.68% | +7.34% | +40.55% | -0.33% | +23.67% | +104.44% | 83.28B | |
| -4.30% | +115.47% | +156.87% | +196.27% | +370.97% | +412.13% | +23.29% | -64.83% | - | 57.94B | |
| +1.32% | +8.54% | +47.18% | +73.96% | -0.78% | -20.84% | -34.97% | -45.19% | +56.57% | 57.77B | |
| +1.42% | +1.61% | +3.62% | +11.17% | -7.20% | -0.67% | +34.08% | +7.02% | - | 51.75B | |
| -0.77% | +2.14% | -10.57% | -9.09% | -7.80% | +11.51% | +170.00% | +120.44% | +201.78% | 49.35B | |
| +0.62% | +4.29% | +7.88% | +12.57% | +23.94% | +56.57% | -16.88% | -37.57% | -29.49% | 32.03B | |
| +0.13% | +3.63% | +8.76% | +31.72% | +29.57% | +50.49% | +99.25% | +69.42% | +55.24% | 25.91B | |
| -2.83% | +4.35% | +10.62% | +22.92% | +30.49% | +0.05% | +187.16% | +51.10% | - | 22.74B | |
| -1.74% | -1.27% | -1.18% | +2.40% | +35.82% | +55.54% | +107.91% | +153.65% | +346.64% | 16.87B | |
| +0.16% | +2.07% | +38.65% | +14.31% | -7.31% | -1.27% | +793.14% | +524.98% | +6,772.58% | 16.08B | |
| -0.53% | +1.48% | -3.51% | +17.29% | +5.99% | +65.18% | +188.71% | +62.63% | - | 15.93B | |
| -2.44% | -2.36% | +9.67% | +20.30% | +9.49% | +11.08% | -30.14% | -15.76% | -31.60% | 12.91B | |
| -1.14% | -5.03% | -14.77% | -12.96% | +12.46% | +73.32% | +172.41% | +725.23% | +2,686.97% | 10.88B | |
| -1.40% | +1.78% | +1.95% | +14.12% | +38.61% | +127.08% | +175.23% | +508.58% | - | 10.26B | |
| -3.29% | +13.17% | +55.98% | +132.46% | +343.88% | +392.48% | +634.10% | +22.97% | - | 9.13B | |
| -0.32% | +0.67% | +2.32% | +4.35% | -7.66% | -20.29% | -24.17% | -52.61% | -49.20% | 6.97B | |
| -8.81% | -10.94% | +1.76% | +1.95% | +5.76% | +17.98% | +239.82% | +225.76% | - | 6.35B | |
| +0.44% | +0.25% | +26.32% | +49.10% | +92.44% | +135.20% | +349.75% | +505.49% | - | 6.17B | |
| -4.33% | -11.79% | +3.43% | +21.02% | -3.82% | -4.49% | +56.78% | -17.04% | - | 6.06B | |
| Average | -1.50% | +8.95% | +19.54% | +33.34% | +51.17% | +73.77% | +164.48% | +145.68% | +1,011.39% | 26.23B | |
| Weighted average by Cap. | -0.88% | +18.35% | +31.39% | +45.12% | +57.06% | +76.79% | +92.80% | +66.00% | +530.81% |
- Stock Market
- Stocks
- ABEO Stock
- Stock
- Sector Plasmatech Biopharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
